Prostaglandin D2 synthase/GPR44: A signaling axis in PNS myelination

Nature Neuroscience

Volumn 17, Issue 12, 2014, Pages 1682-1692

  Trimarco, Amelia ^a   Forese, Maria Grazia ^a   Alfieri, Valentina ^a   Lucente, Alessandra ^a   Brambilla, Paola ^a   Dina, Giorgia ^a   Pieragostino, Damiana ^b   Sacchetta, Paolo ^b   Urade, Yoshihiro ^c   Boizet Bonhoure, Brigitte ^d   Boneschi, Filippo Martinelli ^a   Quattrini, Angelo ^a   Taveggia, Carla ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 44; GAMMA SECRETASE; NEU DIFFERENTIATION FACTOR; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2 SYNTHASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFATC4; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; ISOMERASE; LIPOCALIN; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN R2 D-ISOMERASE; PROSTAGLANDIN RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLIA CELL; HYPOMYELINATION; IN VITRO STUDY; IN VIVO STUDY; MYELINATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION; SPINAL GANGLION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; FEMALE; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; MYELIN SHEATH; MYELINATED NERVE; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; CELLS, CULTURED; FEMALE; GANGLIA, SPINAL; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; NERVE FIBERS, MYELINATED; PERIPHERAL NERVOUS SYSTEM; RATS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

EID: 84925224951     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3857     Document Type: Article

References (59)

1. Birchmeier, C. & Nave, K.A. Neuregulin-1, a key axonal signal that drives Schwann cell growth and differentiation. Glia 56, 1491-1497 (2008).
2. Willem, M. et al. Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314, 664-666 (2006).
3. Hu, X. et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525 (2006).
4. La Marca, R. et al. TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857-865 (2011).
5. Bao, J., Wolpowitz, D., Role, L.W. & Talmage, D.A. Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161, 1133-1141 (2003).
6. Bao, J. et al. Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat. Neurosci. 7, 1250-1258 (2004).
7. Chen, Y., Hancock, M.L., Role, L.W. & Talmage, D.A. Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J. Neurosci. 30, 9199-9208 (2010).
8. Urade, Y. & Eguchi, N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat. 68-69, 375-382 (2002).
9. Giacomelli, S., Leone, M.G., Grima, J., Silvestrini, B. & Cheng, C.Y. Astrocytes synthesize and secrete prostaglandin D synthetase in vitro. Biochim. Biophys. Acta 1310, 269-276 (1996).
10. Samy, E.T. et al. Sertoli cell prostaglandin D2 synthetase is a multifunctional molecule: its expression and regulation. Endocrinology 141, 710-721 (2000).
11. Nagata, N. et al. De novo synthesis, uptake and proteolytic processing of lipocalintype prostaglandin D synthase, beta-trace, in the kidneys. FEBS J. 276, 7146-7158 (2009).
12. Tootle, T.L. Genetic insights into the in vivo functions of prostaglandin signaling. Int. J. Biochem. Cell Biol. 45, 1629-1632 (2013).
13. Haskew-Layton, R.E., Payappilly, J.B., Xu, H., Bennett, S.A. & Ratan, R.R. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) protects neurons from oxidative death via an Nrf2 astrocyte-specific mechanism independent of PPARgamma. J. Neurochem. 124, 536-547 (2013).
14. Kerr, B.J., Girolami, E.I., Ghasemlou, N., Jeong, S.Y. & David, S. The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. Glia 56, 436-448 (2008).
15. Urade, Y. & Hayaishi, O. Prostaglandin D synthase: structure and function. Vitam. Horm. 58, 89-120 (2000).
16. Kostenis, E. & Ulven, T. Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol. Med. 12, 148-158 (2006).
17. Beuckmann, C.T. et al. Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J. Comp. Neurol. 428, 62-78 (2000).
18. Kao, S.C. et al. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 323, 651-654 (2009).
19. Grimwood, S. et al. Determination of guinea-pig cortical gamma-secretase activity ex vivo following the systemic administration of a gamma-secretase inhibitor. Neuropharmacology 48, 1002-1011 (2005).
20. Beuckmann, C.T. et al. Lipocalin-type prostaglandin D synthase (beta-trace) is located in pigment epithelial cells of rat retina and accumulates within interphotoreceptor matrix. J. Neurosci. 16, 6119-6124 (1996).
21. Mohri, I. et al. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J. Neurosci. 26, 4383-4393 (2006).
22. Subra, C. et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J. Lipid Res. 51, 2105-2120 (2010).
23. Irikura, D. et al. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase. J. Biol. Chem. 284, 7623-7630 (2009).
24. Vesin, M.F., Urade, Y., Hayaishi, O. & Droz, B. Neuronal and glial prostaglandin D synthase isozymes in chick dorsal root ganglia: a light and electron microscopic immunocytochemical study. J. Neurosci. 15, 470-476 (1995).
25. Ragolia, L. et al. Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J. Biol. Chem. 280, 29946-29955 (2005).
26. Qu, W.M. et al. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc. Natl. Acad. Sci. USA 103, 17949-17954 (2006).
27. Kanekiyo, T. et al. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA 104, 6412-6417 (2007).
28. Moniot, B. et al. The PGD2 pathway, independently of FGF9, amplifies SOX9 activity in Sertoli cells during male sexual differentiation. Development 136, 1813-1821 (2009).
29. Raff, M.C., Abney, E., Brockes, J.P. & Hornby-Smith, A. Schwann cell growth factors. Cell 15, 813-822 (1978).
30. Monje, P.V., Athauda, G. & Wood, P.M. Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation. J. Biol. Chem. 283, 34087-34100 (2008).
31. Taveggia, C. et al. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47, 681-694 (2005).
32. Ogata, T. et al. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J. Neurosci. 24, 6724-6732 (2004).
33. Newbern, J.M. et al. Specific functions for ERK/MAPK signaling during PNS development. Neuron 69, 91-105 (2011).
34. Lal, M. & Caplan, M. Regulated intramembrane proteolysis: signaling pathways and biological functions. Physiology (Bethesda) 26, 34-44 (2011).
35. Harizi, H. The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity. Biomed. Res. Int. 2013, 683405 (2013).
36. Taketomi, Y. et al. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat. Immunol. 14, 554-563 (2013).
37. Tin, A. et al. Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans. Nephrol. Dial. Transplant. 28, 1497-1504 (2013).
38. Greenberg, M.E., Xu, B., Lu, B. & Hempstead, B.L. New insights in the biology of BDNF synthesis and release: implications in CNS function. J. Neurosci. 29, 12764-12767 (2009).
39. Evans, S.F. et al. Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation. J. Biol. Chem. 286, 29556-29567 (2011).
40. Nicholson, J.D. et al. PGJ(2) provides prolonged CNS stroke protection by reducing white matter edema. PLoS ONE 7, e50021 (2012).
41. Kipanyula, M.J. et al. Calcineurin-nuclear factor of activated T cells regulation of Krox-20 expression in Schwann cells requires elevation of intracellular cyclic AMP. J. Neurosci. Res. 91, 105-115 (2013).
42. Hirahara, Y. et al. G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination. Glia 61, 420-431 (2013).
43. Hennen, S. et al. Decoding signaling and function of the orphan G protein-coupled receptor GPR17 with a small-molecule agonist. Sci. Signal. 6, ra93 (2013).
44. Monk, K.R. et al. A G protein-coupled receptor is essential for Schwann cells to initiate myelination. Science 325, 1402-1405 (2009).
45. Monk, K.R., Oshima, K., Jors, S., Heller, S. & Talbot, W.S. Gpr126 is essential for peripheral nerve development and myelination in mammals. Development 138, 2673-2680 (2011).
46. Glenn, T.D. & Talbot, W.S. Analysis of Gpr126 function defines distinct mechanisms controlling the initiation and maturation of myelin. Development 140, 3167-3175 (2013).
47. Mogha, A. et al. Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation. J. Neurosci. 33, 17976-17985 (2013).
48. Ganfornina, M.D. et al. ApoD, a glia-derived apolipoprotein, is required for peripheral nerve functional integrity and a timely response to injury. Glia 58, 1320-1334 (2010).
49. Comley, L.H. et al. ApoE isoform-specific regulation of regeneration in the peripheral nervous system. Hum. Mol. Genet. 20, 2406-2421 (2011).
50. Michailov, G.V. et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703 (2004).
51. Eguchi, N. et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc. Natl. Acad. Sci. USA 96, 726-730 (1999).
52. Trivedi, S.G. et al. Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc. Natl. Acad. Sci. USA 103, 5179-5184 (2006).
53. Nelson, A.M. et al. Prostaglandin D2 inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44. J. Invest. Dermatol. 133, 881-889 (2013).
54. Quattrini, A. et al. Beta 4 integrin and other Schwann cell markers in axonal neuropathy. Glia 17, 294-306 (1996).
55. Bolis, A. et al. Dlg1, Sec8 and Mtmr2 regulate membrane homeostasis in Schwann cell myelination. J. Neurosci. 29, 8858-8870 (2009).
56. Wrabetz, L. et al. A minimal human MBP promoter-lacZ transgene is appropriately regulated in developing brain and after optic enucleation, but not in shiverer mutant mice. J. Neurobiol. 34, 10-26 (1998).
57. Song, W.L., Lawson, J.A., Wang, M., Zou, H. & FitzGerald, G.A. Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method. Methods Enzymol. 433, 51-72 (2007).
58. Pellegatta, M. et al. alpha6beta1 and alpha7beta1 integrins are required in Schwann cells to sort axons. J. Neurosci. 33, 17995-18007 (2013).
59. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 3 (2004).